WSJ's Take On the Week brings you the insights and analysis you need to get a leg up on the world of money and investing. We cut through the noise and dive into markets, the economy and finance. Join The Wall Street Journal's Telis Demos and Gunjan Banerji in conversation with the people closest to the hot topics in markets to get incisive analysis on the big trades, key players in finance and business news. The duo will bring actionable insights to a range of investors and business leaders while also entertaining a broader audience with lively, relatable conversations. Episodes drop Sundays.
All content for WSJ's Take On the Week is the property of The Wall Street Journal and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
WSJ's Take On the Week brings you the insights and analysis you need to get a leg up on the world of money and investing. We cut through the noise and dive into markets, the economy and finance. Join The Wall Street Journal's Telis Demos and Gunjan Banerji in conversation with the people closest to the hot topics in markets to get incisive analysis on the big trades, key players in finance and business news. The duo will bring actionable insights to a range of investors and business leaders while also entertaining a broader audience with lively, relatable conversations. Episodes drop Sundays.
WSJ’s Take On the Year: Market Trends to Watch in 2025
WSJ's Take On the Week
24 minutes
3 months ago
WSJ’s Take On the Year: Market Trends to Watch in 2025
AI was a big stock market theme in 2024. We’ve talked about it, and heard it many times. But it was far from the only thing that happened in stocks last year. We saw record-breaking growth from power companies like Vistra. Cult stocks like Palantir and MicroStrategy also had a moment. And of course, Nvidia, a company that needs no introduction, had a blockbuster year.
But where there are winners, there are also losers. The announcement of Walgreens’ potential sale highlighted the challenges within the retail pharmacy sector. Shares of the biotech company Moderna also slumped partly due to waning demand for its Covid-19 vaccine and booster. And discount chain Dollar Tree took a hit this year as its shoppers showed signs of belt-tightening.
For our first episode of 2025, we’re joined by global editor of WSJ’s Heard on the Street column, Spencer Jakab, and deputy editor of WSJ’s Heard on the Street, Aaron Back, to reveal more of the market’s winners and losers in 2024 and examine what their wins or losses could mean for investors and the economy in the year ahead.
Further Reading
Walgreens Is in Talks to Sell Itself to Private-Equity Firm Sycamore Partners
Tech-Loving Hedge Funds Have a Crush on Utility Stocks
For more coverage of the markets and your investments, head to WSJ.com, WSJ’s Heard On The Street Column, and WSJ’s Live Markets blog.
WSJ's Take On the Week
WSJ's Take On the Week brings you the insights and analysis you need to get a leg up on the world of money and investing. We cut through the noise and dive into markets, the economy and finance. Join The Wall Street Journal's Telis Demos and Gunjan Banerji in conversation with the people closest to the hot topics in markets to get incisive analysis on the big trades, key players in finance and business news. The duo will bring actionable insights to a range of investors and business leaders while also entertaining a broader audience with lively, relatable conversations. Episodes drop Sundays.
